Phase 3 trial of whole brain radiation therapy in addition to radiosurgery for brain metastases

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Andrew B. Lassman, MD, of Columbia University Medical Center, New York, NY, discusses the results of the randomised phase 3 NCCTG N0574 (Alliance) trial of whole brain radiation therapy in addition to stereotactic radiosurgery in patients with 1 to 3 brain metastases.

Year of Production:
Running Time:
Color/Sound:

2015
04:46
Color/Sound

Comments are closed.